Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
about
Arrhythmogenic right ventricular cardiomyopathy/dysplasiaNaxos disease: cardiocutaneous syndrome due to cell adhesion defectCardiomyopathy classification: ongoing debate in the genomics eraCoenzyme Q10 for heart failurePacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathyCorticosteroids for viral myocarditisPacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathyIdiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutationsPrevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathyABCA5 resides in lysosomes, and ABCA5 knockout mice develop lysosomal disease-like symptomsAtrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanismsThe Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathyANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy geneThe locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14.Cardiovascular magnetic resonance in myocarditis: A JACC White PaperA systematic review of intravenous gamma globulin for therapy of acute myocarditis.Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and TreatmentCardiovascular Actions and Therapeutic Potential of Tetramethylpyrazine (Active Component Isolated from Rhizoma Chuanxiong): Roles and MechanismsArrhythmogenic cardiomyopathyCardiac Magnetic Resonance Scar Imaging for Sudden Cardiac Death Risk Stratification in Patients with Non-Ischemic CardiomyopathyUpdate on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac DiseaseKATP channels and cardiovascular disease: suddenly a syndromeArrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular diseaseEndomyocardial fibrosis: still a mystery after 60 yearsAcute viral myocarditisGenetics and disease of ventricular muscle.Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathyHLA-DR3 antigen in the resistance to idiopathic dilated cardiomyopathy2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theSystematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathyExtracardiac medical and neuromuscular implications in restrictive cardiomyopathyThe ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathyAdrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in miceHistological and ultrastructural abnormalities in murine desmoglein 2-mutant heartsMutation of junctophilin type 2 associated with hypertrophic cardiomyopathyEffect of lovastatin on coxsackievirus B3 infection in human endothelial cellsThe effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performanceLong term treatment with enalapril reduces plasma concentrations of macrophage colony stimulating factor in patients with coronary artery diseaseCardiomyopathy in α-kinase 3 (ALPK3)-deficient miceAlcoholic cardiomyopathy : The result of dosage and individual predisposition
P2860
Q21202959-D755E05F-DBF5-48A0-A698-C3DDE3D18E66Q21203030-33A0F49C-C835-48F7-803D-7039DFC9B166Q21284968-25D18E75-BDBD-42E8-95D8-D32642FF5006Q24194154-DE9E4E91-7CDB-43D4-BB71-1C40742969F5Q24197872-BF2E17A8-D45D-4F04-AF49-DB231985B22CQ24202995-50085FA1-0C5A-4142-BBE9-F2E53318DB16Q24235537-3F832F2C-0000-43A4-88A9-C9621186AF9FQ24292763-6B67EE3B-6450-413D-9875-3892FADAC2A1Q24300812-3C4C20B9-5CA8-49D0-89C1-957FCE5F31BEQ24301397-400C63BA-E28D-4FFD-B2B5-1EDBC1F56A63Q24309993-30B3D9CB-5C40-4455-934E-5C6A285E9C41Q24311983-B98662F9-899B-4017-844B-386D63B40C54Q24315109-FB7FB048-EED2-405E-8B6B-04A1E7945A4FQ24534286-2E1AA1A3-1828-4B17-B3F5-ACF42464176BQ24654343-275650F4-5451-4242-A17A-4C6A6099AF37Q24815545-E5827F53-77D1-4BCC-9A8A-407C000B8CF3Q26744257-5ACAA97C-F0EE-4FDB-9256-DC39810A6A92Q26744567-5187815C-C548-47A4-8608-FB3E71E20445Q26753099-D55834BF-7533-4B9B-85A3-5844FBC20123Q26801712-09524293-EC05-43D0-A05E-3225E55A50F1Q26801907-6294DB1D-5860-486C-B2CD-7FC9E1EB8501Q27013265-5E528A4D-7670-4A24-89EA-6C5C8323E67FQ27024037-F1F18552-1E3A-44B1-A03B-1F862F433843Q27306973-8631ABD5-97B8-4628-84B2-EE5F76CA3586Q27486698-D3375AD0-4264-4241-B3AC-AD2DA8FC5DDCQ27691994-72D577DA-FAFF-47C8-B62F-6D1CD503D242Q28067623-D9C3B94C-1E64-4737-A12A-90D9CE3518CFQ28078313-3AD98827-7BCB-4FC4-A6DE-85B6DA3C6E2DQ28087002-B49A5E43-5292-457B-9346-BC54AC6C6FADQ28211536-E33B766A-0CDD-4F9E-90DF-D439CD926180Q28239607-ABE489FA-C5FD-4B68-B925-643FAEE46B46Q28252486-BDF654D7-AB5B-4660-AAA1-856AD30317C0Q28252819-9A0E633E-0754-4BDF-AE65-4578578E148EQ28258584-5ECFC455-57F3-4CAC-ADA1-E878D0790B21Q28300361-4A4A346E-C0D8-4A55-A616-0B0388EBC2E9Q28303547-634FED9A-314C-4FE5-A904-051A6BD382BFQ28303831-3BA5A49F-ECE0-4592-BCFA-514A1966FDE9Q28354006-16838787-F9D6-4CC7-A7C7-8D06FB71B2A8Q28589708-A619693A-6925-45DC-80A8-4AE1E0EECB2DQ28596225-CC962A30-860C-446F-84E1-3B3171B28BE7
P2860
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Report of the 1995 World Healt ...... ification of cardiomyopathies.
@en
Report of the 1995 World Healt ...... ification of cardiomyopathies.
@nl
type
label
Report of the 1995 World Healt ...... ification of cardiomyopathies.
@en
Report of the 1995 World Healt ...... ification of cardiomyopathies.
@nl
prefLabel
Report of the 1995 World Healt ...... ification of cardiomyopathies.
@en
Report of the 1995 World Healt ...... ification of cardiomyopathies.
@nl
P2093
P356
P1433
P1476
Report of the 1995 World Healt ...... ification of cardiomyopathies.
@en
P2093
O'Connell J
P304
P356
10.1161/01.CIR.93.5.841
P407
P577
1996-03-01T00:00:00Z